Skip to main content
PMC home page
Evidence-based Complementary and Alternative Medicine : eCAM logoLink to Evidence-based Complementary and Alternative Medicine : eCAM
. 2012 Feb 28;2012:623723. doi: 10.1155/2012/623723

Antibacterial Activities of Selected Cameroonian Plants and Their Synergistic Effects with Antibiotics against Bacteria Expressing MDR Phenotypes

Stephen T Lacmata 1, Victor Kuete 1,*, Jean P Dzoyem 1, Simplice B Tankeo 1, Gerald Ngo Teke 1, Jules R Kuiate 1,*, Jean-Marie Pages 2
PMCID: PMC3304440  PMID: 22474511

Abstract

The present work was designed to assess the antibacterial properties of the methanol extracts of some Cameroonian medicinal plants and the effect of their associations with currently used antibiotics on multidrug resistant (MDR) Gram-negative bacteria overexpressing active efflux pumps. The antibacterial activities of twelve methanol extracts of medicinal plants were evaluated using broth microdilution. The results of this test showed that three extracts Garcinia lucida with the minimal inhibitory concentrations (MIC) varying from 128 to 512 μg/mL, Garcinia kola (MIC of 256 to 1024 μg/mL), and Picralima nitida (MIC of 128 to 1024 μg/mL) were active on all the twenty-nine studied bacteria including MDR phenotypes. The association of phenylalanine arginine β-naphthylamide (PAβN or efflux pumps inhibitor) to different extracts did not modify their activities. At the concentration of MIC/2 and MIC/5, the extracts of P. nitida and G. kola improved the antibacterial activities of some commonly used antibiotics suggesting their synergistic effects with the tested antibiotics. The results of this study suggest that the tested plant extracts and mostly those from P. nitida, G. lucida and G. kola could be used alone or in association with common antibiotics in the fight of bacterial infections involving MDR strains.

1. Introduction

Bacterial infections are responsible for 90% of infections found in health care services. The emergence of MDR bacterial strains appears as the major cause of treatment failure [1]. Among the known mechanisms of resistances, active efflux via resistance-nodulation-cell division (RND) pumps is one of the most occurring system in Gram-negative bacterial strains [2]. Efflux pumps are transport proteins involved in the extrusion of toxic substrates (including virtually all classes of clinically relevant antibiotics). The present work was therefore designed to investigate the antibacterial potential against MDR bacteria expressing active efflux though RND pumps. Medicinal plants of Cameroon used in this study include the fruits of Citrus medica L. (Rutaceae), the bulbs of Allium sativum L. (Liliaceae) and Allium cepa L. (Liliaceae), the seeds of Carica papaya Linn (Caricaceae), Cola acuminata (P. Beauv.) Schott and Endl. (Sterculiaceae), Buchholzia coriacea Engl. (Capparidaceae), Garcinia kola Heckel (Guttifeare), and Garcinia lucida Vesque (Guttifeare), the seeds and fruits of Picralima nitida; the potential of the extract from the above plant extracts to increase the activity of some antibiotics on MDR bacteria was also investigated as well as the role of bacterial efflux pumps in the resistance to the tested plant extracts.

2. Material and Methods

2.1. Plant Materials and Extraction

The nine edible plants used in this work were purchased from Dschang local market, west region of Cameroon in January 2010. The collected vegetal material were the fruits of Citrus medica, the bulbs of Allium sativum and Allium cepa, the seeds of Carica papaya, Cola acuminata, Buchholzia coriacea, Garcinia kola, and Garcinia lucida, the seeds and fruits of Picralima nitida. The plants were identified by Mr. Tadjouteu Fulbert (Botanist) of the National Herbarium (Yaoundé, Cameroon) where voucher specimens were deposited under a reference number (Table 1).

Table 1.

Plants used in the present study and evidence of their activities.

Plant (family); and voucher numbera Traditional uses Parts used Bioactive or potentially bioactive Components bBioactivities of crude extracts
Allium sativum Liliaceae;
44810/HNC		 Cardiovascular diseases, intoxication, inflammations [7], fungi and parasitic infections, respiratory diseases, and asthma [8] Bulbs Allicine [7] Antimicrobial: essential oil against Haemonchus contortus [8]
Allium cepa (Liliaceae); 034/UDS Cardiovascular diseases, intoxication, inflammations, bacterial and fungal infections [7] Bulbs Sulfur component [9] Antimicrobial: crude extract against Ec, St, and Bs [9]
Carica papaya (Caricaceae); 18647/SRF-CAM Gastroenteritis, oxidative stress, intestinal worms, hepatitis, cancer, and asthma [10] Seeds, fruits, leaf, and bark Alkaloids, steroids, triterpenes and flavonoids [11] Antimicrobial: seeds, fruits, and bark methanol and aqueous extract active against Sa, Ec, Pa, Pv, St, Kp, Ec, and Bs [12]
Buchholzia coriacea (Capparidaceae); 32124/SRF-CAM Gastroenteritis [7] Seeds, bark Alkaloids, anthraquinones, tannins, cardiaques glycosides, flavonoids glycosides, saponines, steroids, steroids terpenes [13], Antimicrobial: Seeds methanol and aqueous extract against Sa, St, Bc, Ec [13, 14]
Citrus medica (Rutaceae); 65106/HNC Atheriosclerosis, influenza, infectious diseases, urinary and cholelithiasis, hypertension, dysentery, diarrhea, rheumatism, gout, worms, anemia, seasickness, pulmonary troubles, and intestinal ailments [15] Fruits flavonoids, phenolics, glycosides, and steroids [16] Antimicrobial: fruit extract against Ca, Ck, Tr, Pa, Sf, St, Ec, Sa, Kp, Pv, Bc, Bm, Bs, Bst, Cf, Mm, Pm, Shf, Stm, Sp, and Ng [16]
Cola acuminata (Sterculiaceae); 1729/SRFK Cellulite, Asthenia, sexual Asthenia, physical and intellectual fatigue, and gastrointestinal infections [17] Seeds Alkaloids (colanine or catechin-caffeine, caffeine, kolatine) [17] —
Garcinia kola (Clusiaceae) 27839/SRF-CAM Nervous alertness and induction of insomnia, purgative, wound healing, and cancers [18, 19] Roots, seeds, and latex kolanone, kolaflavanone, and garciniaflavanone [20, 21] Antimicrobial: seeds ethanol extract against Sa, Sp, Spn, and Hi [22]; cytotoxicity of fruits crude methanol extract: weak activity on leukemia CCRF-CEM and pancreatic MiaPaCa-2 cell lines [19]
Garcinia lucida (Clusiaceae); 17974/SRF-CAM Gastrointestinal infections, poison, and cancers [8, 19, 23] Bark, seeds, and roots Dihydrochelerithrine, 6-acétonyldihydrochelerithrine, and lucidamine [24] Antimicrobial: Seeds methylene chloride extract as β-lactamase inhibitor [25]; cytotoxicity of fruits crude methanol extract: weak activity on leukemia CCRF-CEM and CEM/ADR5000 cells and pancreatic MiaPaCa-2 cell lines [19]
Picralima nitida (Apocynaceae) 1942/SRFK Malaria and fever [26–28], diabetes, inflammation [29, 30], and cancers [19] Seeds, fruits, leaf, bark, and roots Akuammicine, akuammidine, akuammine, picracine, picraline pseudo-akuammigine [31]; glycosides, saponins, tannins, flavonoids, terpenoides and alkaloids [32] Antimicrobial: fruits aqueous, methanol and dichloromethane against PF [31]; root and stem bark (aqueous and ethanol) against Sa, Pa, Ec, and Bs [32]; cytotoxicity of fruits crude methanol extract: weak activity on leukemia CCRF-CEM cell line [19]
Open in a new tab

a(HNC): Cameroon National Herbarium; (SRFC): Société des réserves forestières du Cameroun; (UDs): University of Dschang; Microorganisms (Ca: Candida albicans; Ck: Candida krusei; Bc: Bacillus cereus; Bm: Bacillus megaterium; Bs: Bacillus subtilis; Bst: Bacillus stearothermophilus; Cf: Citrobacter freundii; Ec: Escherichia coli; Hi: Haemophilus influenzae; Kp: Klebsiella pneumoniae; Mm: Morganella morganii; Ng: Neisseria gonorrhoeae; Pa: Pseudomonas aeruginosa; Pf: Plasmodium falciparum; Pm: Proteus mirabilis; Pv: Proteus vulgaris; Sa: Staphylococcus aureus; Spn: Streptococcus pneumoniae; Sp: Streptococcus pneumoniae; St: Salmonella typhi; Tr: Trichophyton rubrum; Sf: Streptococcus faeealis; Shf: Shigella flexneri; Stm: Salmonella typhimurium; Sp: Streptococcus pneumonia). bScreened activity: significant (S: CMI < 100 μg/mL). Moderate (M: 100 < CMI ≤ 625 μg/mL). Weak (W: CMI > 625 μg/mL). Q: qualitative activity based on the determination of inhibition zone [33].

The fresh or powdered air-dried sample (1 kg) from each plant was extracted with methanol (MeOH) for 48 h at room temperature. The extract was then concentrated under reduced pressure to give a residue that constituted the crude extract. They were then kept under 4°C until further use.

2.2. Preliminary Phytochemical Investigations

The presence of major secondary metabolite classes, namely, alkaloids, flavonoids, phenols, saponins, tannins, anthocyanins, anthraquinones, sterol, and triterpenes was determined using common phytochemical methods as described by Harborne [3].

2.3. Chemicals for Antimicrobial Assays

Ciprofloxacin (CIP), chloramphenicol (CHL), streptomycin (STR), tetracycline (TET), norfloxacin (NFX), cloxacillin (CLX), ampicillin (AMP), erythromycin (ERY), kanamycin (KAN), and cefepim (CEF) (Sigma-Aldrich, St Quentin Fallavier, France) were used as reference antibiotics. p-Iodonitrotetrazolium chloride (INT) and phenylalanine arginine β-naphthylamide (PAβN) were used as microbial growth indicator and efflux pumps inhibitor (EPI), respectively.

2.4. Bacterial Strains and Culture Media

The studied microorganisms include references (from the American Type Culture Collection) and clinical (Laboratory collection) strains of Escherichia coli, Enterobacter aerogenes, Providencia stuartii, Pseudomonas aeruginosa, Klebsiella pneumonia, and Enterobacter cloacae (Table 2). They were maintained on agar slant at 4°C and subcultured on a fresh appropriate agar plates 24 hrs prior to any antimicrobial test. Mueller Hinton Agar was used for the activation of bacteria. The Mueller Hinton Broth (MHB) was used for the MIC determinations.

Table 2.

Bacterial strains and features.

Strains Features References
Escherichia coli
 ATCC8739 and ATCC10536 Reference strains
 AG100 Wild-type E. coli K-12 [31]
 AG100A AG100 ΔacrAB::KANR [31, 34]
 AG100ATET ΔacrAB mutant AG100, owing acrF gene markedly overexpressed; TETR [31]
 AG102 ΔacrAB mutant AG100 [35]
 MC4100 Wild type E. coli
 W3110 Wild type E. coli [36]
Enterobacter aerogenes
 ATCC13048 Reference strains
 EA-CM64 CHLR resistant variant obtained from ATCC13048 over-expressing the AcrAB pump [37]
 EA3 Clinical MDR isolate; CHLR, NORR, OFXR, SPXR, MOXR, CFTR, ATMR, FEPR [38]
 EA27 Clinical MDR isolate exhibiting energy-dependent norfloxacin and chloramphenicol efflux with KANR and AMPR and NALR and STRR and TETR [38, 39]
 EA289 KAN sensitive derivative of EA27 [40]
 EA298 EA 289 tolC::KANR [40]
 EA294 EA 289 ΔacrAB: ::KANR [40]
Enterobacter cloacae
 ECCI69 Clinical isolates Laboratory collection of UMR-MD1, University of Marseille, France
 BM47 Clinical isolates Laboratory collection of UMR-MD1, University of Marseille, France
 BM67 Clinical isolates Laboratory collection of UMR-MD1, University of Marseille, France
Klebsiella pneumoniae
 ATCC12296 Reference strains
 KP55 Clinical MDR isolate, TETR, AMPR, ATMR, and CEFR [41]
 KP63 Clinical MDR isolate, TETR, CHLR, AMPR, and ATMR [41]
 K24 AcrAB-TolC Laboratory collection of UMR-MD1, University of Marseille, France
 K2 AcrAB-TolC Laboratory collection of UMR-MD1, University of Marseille, France
Providencia stuartii
 NEA16 Clinical MDR isolate, AcrAB-TolC
 ATCC29914 Clinical MDR isolate, AcrAB-TolC [42]
 PS2636 Clinical MDR isolate, AcrAB-TolC
 PS299645 Clinical MDR isolate, AcrAB-TolC
Pseudemonas aeruginosa
 PA 01 Reference strains
 PA 124 MDR clinical isolate [43]
Open in a new tab

aAMP, ATMR, CEFR, CFTR, CHLR, FEPR, KANR, MOXR, STRR, and TETR. Resistance to ampicillin, aztreonam, cephalothin, cefadroxil, chloramphenicol, cefepime, kanamycin, moxalactam, streptomycin, and tetracycline; MDR: multidrug resistant.

2.5. Bacterial Susceptibility Determinations

The respective MICs of samples on the studied bacteria were determined by using rapid INT colorimetric assay [4]. Briefly, the test samples were first dissolved in DMSO/MHB. The solution obtained was then added to MHB, and serially diluted twofold (in a 96-well microplate). One hundred microlitres (100 μL) of inoculum (1.5 × 106 CFU/mL) prepared in MHB was then added. The plates were covered with a sterile plate sealer, then agitated to mix the contents of the wells using a shaker and incubated at 37°C for 18 hrs. The final concentration of DMSO was lower than 2.5% and does not affect the microbial growth. Wells containing MHB, 100 μL of inoculums, and DMSO at a final concentration of 2.5% served as a negative control. Ciprofloxacin was used as reference antibiotic. The MICs of samples were detected after 18 hrs of incubation at 37°C, following addition (40 μL) of 0.2 mg/mL INT and incubation at 37°C for 30 minutes [5]. Viable bacteria reduced the yellow dye to pink. MIC was defined as the lowest sample concentration that prevented this change and exhibited complete inhibition of microbial growth.

Samples were tested alone and then, in the presence of PAβN at 30 μg/mL final concentration. Two of the best extracts, those from seeds of Garcinia kola and Picralima nitida fruits were also tested in association with antibiotics at MIC/2 and MIC/5. These concentrations were selected following a preliminary assay on one of the tested MDR bacteria, P. aeruginosa PA124 (see Supplemental Material S1 available online at doi:10.1155/2012/623723.). All assays were performed in triplicate and repeated thrice. Fractional inhibitory concentration (FIC) was calculated as the ratio of MICAntibiotic  in  combination/MICAntibiotic  alone and the interpretation made as follows: synergistic (FIC ≤ 0.5), indifferent (0.5 < FIC < 4), or antagonistic (FIC ≥ 4) [6]. (The FIC values are available in Supplemental Material S2).

3. Results

3.1. Phytochemical Composition of the Plant Extracts

The results of qualitative analysis showed that each plant contains various phytochemicals compounds such as alkaloids, anthocyanins, anthraquinons, flavonoids, phenols, saponins, tannins, and triterpenes as shown in Table 3.

Table 3.

Extraction yields, aspects, and phytochemical composition of the plant extracts.

Scientific names Part used Yield (%) Physical aspect Phytochemical composition
Alkaloids Flavonoids Phenols Tannins Anthraquinones Anthocyanins Triterpenes Sterols Saponins
Picralima nitida Fruits 13.56 Brown paste + + + − + + + − +
Seeds 17.27 Brown paste + + + + + − + − +
Citrus medica Fruits 14.06 Brown paste − + + − − − − − −
Allium sativum Dry bulbs 18.99 Yellow powder − − − − − − − − −
Fresh bulbs 4.04 Brown powder − − − − − − − − −
Buchholzia coriacea Seeds 6.36 Brown paste + − − − + − − − −
Cola acuminata Seeds 8.81 Brown paste + − + + + − + − +
Garcinia kola Seeds 13.56 Dark brown paste + − + + + − + − +
Garcinia lucida Seeds 23.92 Brown paste + + + + + − − − −
Carica papaya Seeds 6.33 Oily paste + + + − − − − − −
Allium cepa Fresh bulbs 18.93 Brown paste − + + + − − − − −
Dry bulbs 49.26 Brown paste − + + − − − − − −
Open in a new tab

(+): present; (−): absent; *The yield was calculated as the ratio of the mass of the obtained methanol extract/mass of the plant powder or fresh sample.

3.2. Antibacterial Activity of the Plant Extracts

Extracts were tested for their antibacterial activities alone and in combination with PAβN on a panel of Gram-negative bacteria by the microdilution method. Results summarized in Table 4 showed that the most active extracts were those from Garcinia lucida (MIC ranged from 128 to 512 μg/mL), Garcinia kola (MIC from 128 to 1024 μg/mL), and the fruits of Picralima nitida (MIC from 256 to 1024 μg/mL). The antibacterial activities of these plant species were recorded against all the 29 studied microorganisms. Other extracts exhibited weak activities against a limited number of strains studied.

Table 4.

Minimal inhibitory concentration (μg/mL) of methanol extracts from the studied plants and ciprofloxacin.

Bacteria strains Plants extractsa and MIC (μg/mL) in the absence and presence of PAβN (in bracket)
CAF PNF ASB1 ASB2 BCF PNS CMF GKS GLS CPS ACB1 ACB2 CIP
E. coli
 ATCC8739 — 1024 — — — — — 512 512 — — — <0.5
 ATCC10536 — 1024 — — — 1024 — 512 512 1024 — — 64
 W3110 1024 (1024) 512 (512) — — — — (512) — (1024) 512 (256) 256 (128) — — — (1024) <0.5 (<0.5)
 MC4100 — 512 — — — 1024 — 512 256 — 1024 1024 32
 AG100A 1024 512 (128) — — (512) — — (1024) — 1024 (1024) 256 (64) 1024 (1024) — — 16 (8)
 AG100Atet 1024 (1024) 1024 (512) — — — — — 256 (256) 512 (512) 1024 (1024) 1024 (1024) — 32 (8)
 AG102 — 512 (128) — — (1024) — (1024) — (1024) — (1024) 256 (64) 512 (256) 512 (512) — — 32 (16)
 AG100 — 512 — — 1024 — — 256 256 1024 — 1024 0.5
E. aerogenes
 ATCC13048 — 512 — — — — — 512 256 — — — 1
 EA294 — 1024 — — — — — 512 256 — 1024 — 64
 CM64 1024 512 — — 1024 — 1024 256 256 — 512 — 32
 EA3 — 512 — — — — — 512 256 — — — 32
 EA298 — — (512) — — — — — 512 (128) 256 (128) — — — 1 (<0.5)
 EA27 1024 (1024) 512 (512) — — — — — 256 (256) 256 (256) 1024 (1024) — — 1 (<0.5)
 EA289 — 1024 (1024) — — — — — (1024) 512 (512) 512 (256) — — — 64 (32)
K. pneumoniae
 ATCC11296 1024 (1024) 512 (256) — — (1024) — (1024) — — 512 (512) 256 (128) — (512) — — <0.5 (<0.5)
 KP55 512 (512) 512 (256) — — — — — 512 (512) 128 (128) 1024 (1024) 1024 (1024) — (1024) 32 (4)
 KP63 — 512 — — — — — 512 512 — — — 32
 K2 — 1024 — — — — — 512 (256) 256 (128) 1024 (1024) — (512) — 32 (8)
 K24 512 512 — — — — — 512 256 1024 1024 — 32
P. aeruginosa
 PA01 — 1024 (1024) — — — — — 512 (512) 512 (512) — — — 32 (4)
 PA124 — 512 — — — — — 1024 256 1024 — — 128
P. stuartii
 ATCC29916 1024 (1024) 1024 (1024) — — — — — 512 (512) 256 (128) 1024 (1024) — — >64 (16)
 NAE16 1024 512 — — — 1024 — 256 256 1024 1024 — 64
 PS2636 — 1024 — — — — — 128 128 — — — 64
 PS299645 1024 (1024) 1024 (1024) — 1024 (1024) 1024 (1024) 1024 (1024) 256 (256) 128 (128) 1024 (1024) — — <0.5 (<0.5)
E. cloacae
 BM47 — 256 — — — — — 256 256 — — 1024 64
 ECCI69 1024 512 — — 1024 — 1024 128 128 — — — 128
 BM67 1024 512 — — — — — 256 256 1024 1024 — 32
Open in a new tab

(—) MIC greater than 1024 μg/mL; aExtract from CAF: Cola acuminata fruit; PNF: Picralima nitida fruits; ASB1: Allium sativum dry bulbs; ASB2: Allium sativum fresh bulbs; BCF: Buchholsia coriacea fruits; PNS: Picralima nitida seeds; CMF: Citrus médica fruits juice; GKS: Garcinia kola seeds; GLS: Garcinia lucida seeds; CPS: Carica papaya seeds; ACB1: Allium cepa fresh bulbs; ACB2: Allium cepa dry bulbs; CIP: ciprofloxacin.

3.3. Role of Efflux Pumps in Susceptibility of Gram-Negative Bacteria to the Tested Plants Extracts

The various strains and MDR isolates were also tested for their susceptibility to the plants extracts, and reference antibiotic (ciprofloxacin) in the presence of PAβN, an EPI. Preliminary tests showed that PAβN did not have any antibacterial activity at 30 μg/mL. The association of the PAβN with the extracts reduced the MIC values of some of the extracts on some tested bacteria (Table 4). However, most of the studied extracts are not the substrates of the active efflux pumps.

3.4. Effects of the Association of Some Plants Extracts with Antibiotics

The strain P. aeruginosa PA124 was used to find the appropriate subinhibitory concentration of the antibiotic-crude extract to be tested on other bacteria strains. The association of the extracts of P. nitida and G. kola reduced the MIC of ten antibiotics (CLX, AMP, ERY, KAN, CHL, TET, FEP, STR, CIP, and NOR) at MIC/2 and/or MIC/5 explaining the use of such concentrations. The associations of the extracts of P. nitida fruits and G. kola with antibiotics did not show any case of antagonism (FIC ≥ 4) meanwhile indifference was observed in some cases of the associations of the extracts with FEP, CLX, and AMP (see Tables 5 and 6, Supplemental Material S2). Many cases of synergy were observed in most of the strains with the associations G. kola/ERY against CM64, P. nitida/NOR against KP63, and P. nitida/ERY against PA124.

Table 5.

MIC of different antibiotics after the association of the extract of Picralima nitida fruits at MIC/2, MIC/5 against ten MDR bacteria strains.

Antibiotics Extract concentration Bacterial strains, MIC (μg/mL) of antibiotics in the absence and presence of the extract
AG100 AG100Atet AG102 CM64 EA3 EA27 EA289 KP55 KP63 PA124
CIP 0
MIC/2
MIC/5		 ≤0.5
≤0.5
≤0.5		 128
16(8)S
32(4)S 		32
16(2)S
16(2)S 		≤0.5
≤0.5
≤0.5		 256
64(4)S
128(2)S 		≤0.5
≤0.5
≤0.5		 64
16(4)S
32(2)S 		256
128(2)S
256(1)I 		128
64(2)S
64(2)S 		32
8(4)S
8(4)S
CHL 0
MIC/2
MIC/5		 4
2(2)S
4(1)I 		>512
64(>8)S
128(>4)S 		128
16(8)S
32(4)S 		512
64(8)S
128(4)S 		512
64(8)S
128(4)S 		64
8(8)S
32(2)S 		512
64(8)S
128(4)S 		32
16(2)S
16(2)S 		512
128(4)S
256(2)S 		64
8(8)S
32(2)S
STR 0
MIC/2
MIC/5		 4
2(2)S
2(2)S 		>512 256(>2)S 512(>1) ≤0.5
≤0.5
≤0.5		 512
256(2)S
512(1)I 		>512
64(8)S
256(>2)S 		16
16(1)I
16(1)I 		16
16(1)I
16(1)I 		16
16(1)I
16(1)I 		128
128(1)I
128(1)I 		>512
128
512
AMP 0
MIC/2
MIC/5		 32
16(2)S
16(2)S 		>512
512(1)I
>512		 256
64(4)S
64(4)S 		512
512(1)I
512(1)I 		>512
128(>4)S
512(>1)		 64
64(1)I
64(1)I 		>512
>512
>512		 >512
>512
>512		 >512
>512
>512		 >512
16(>32)S
16(>32)S
TET 0
MIC/2
MIC/5		 64
16(4)S
32(2)S 		256
128(2)S
256(1)I 		8
1(8)S
4(2)S 		128
32(4)S
64(2)S 		512
64(8)S
128(4)S 		8
2(4)S
4(2)S 		32
8(4)S
8(4)S 		8
4(2)S
4(2)S 		16
8(2)S
8(2)S 		8
2(4)S
4(2)S
CLX 0
MIC/2
MIC/5		 64
32(2)S
32(2)S 		>512
>512
>512		 >512
128(>4)S
256(>2)S 		>512
256
>512		 >512
>512
>512		 >512
>512
>512		 >512
>512
>512		 >512
>512
>512		 >512
>512
>512		 >512
512(>1)
>512
KAN 0
MIC/2
MIC/5		 ≤4
≤4
≤4		 512
128(4)S
128(4)		 16
16(1)I
16(1)I 		≤4
≤4
≤4		 ≤4
≤4
≤4		 >512
512(>2)S
>512		 32
≤4(>8)S
16(2)I 		32
8(4)S
8(4)S 		512
128(4)S
512(1)I 		128
64(2)S
64(2)S
ERY 0
MIC/2
MIC/5		 64
32(2)S
64(1)I 		512
256(2)S
256(2)S 		16
16(1)I
16(1)I 		256
32(8)S
256(1)I 		32
8(4)S
16(2)S 		8
4(2)S
8(1)I 		128
128(1)I
128(1)I 		64
16(4)S
32(2)S 		128
64(2)S
128(1)I 		128
8(16)S
8(16)S
NOR 0
MIC/2
MIC/5		 32
16(2)S
32(1)I 		512
128(4)S
128(4)S 		128
32(4)S
64(2)S 		16
8(2)S
16(1)I 		16
4(4)S
16(1)I 		32
16(2)S
16(2)S 		64
32(2)S
32(2)S 		64
32(2)S
32(2)S 		64
4(8)S
16(4)S 		128
32(4)S
32(4)S
FEP 0
MIC/2
MIC/5		 512
256(2)S
512(1)I 		512
128(4)S
512(1)I 		512
512(1)I
512(1)I 		>512
256(>4)S
>512		 256
64(4)S
128(2)S 		512
252(2)S
512(1)I 		512
512(1)I
512(1)I 		>512
>512
>512		 512
256(2)S
512(1)I 		512
512(1)I
512(1)I
Open in a new tab

(): fold increase in MIC values of the antibiotics after association with plants extract; S: synergy, I: indifference; AMP: ampicillin; FEP: cefepime; CHL: chloramphenicol; KAN: kanamycin; NOR: norfloxacin; STR: streptomycin; TET: tetracycline; CIP: ciprofloxacin; CLX: cloxacillin; ERY: erythromycin.

Table 6.

MIC of different antibiotics after the association of the extract of Garcinia kola seeds at MIC/2, MIC/5 against ten MDR bacteria strains.

Antibiotics Extract concentration Bacterial strains, MIC (μg/mL) of antibiotics in the absence and presence of the extract
AG100 AG100Atet AG102 CM64 EA3 EA27 KP55 KP63 EA289 PA124
CIP 0
MIC/2
MIC/5		 ≤0.5
≤0.5
≤0.5		 128
64(2)S
64(2)S 		32
8(4)S
8(4)S 		≤0.5
≤0.5
≤0.5		 256
128(2)S
128(2)S 		≤0.5
≤0.5
≤0.5		 256
128(2)S
256(1)I 		128
32(4)S
128(1)I 		64
32(2)S
64(1)I 		32
<0.5
16(2)S
CHL 0
MIC/2
MIC/5		 4
4(1)I
4(1)I 		>512
512(>1)
512(>1)		 128
16(8)S 32(4)S 		512
256(2)S
512(1)I 		512
512(1)I
512(1)I 		64
8(8)S
16(4)S 		32
32(1)I
32(1)I 		512
128(4)S
256(2)S 		512
128(4)S
256(2)S 		64
32(2)S
32(2) S
STR 0
MIC/2
MIC/5		 4
2(2)S
2(2)S 		>512
>512
>512		 <0.5
<0.5
<0.5		 512
256(2)S
512(1)I 		>512
>512
>512		 16
8(2)S
16(1)I 		16
8(2)S
16(1)I 		128
128(1)I
128(1)I 		16
8(2)S
16(1)I 		>512
16(>32)S
128(>4)S
AMP 0
MIC/2
MIC/5		 32
8(4)S
32(1)I 		>512
>512
>512		 256
128(2)S
128(2)S 		>512
>512
>512		 >512
>512
>512		 64
64(1)I
64(1)I 		>512
>512
>512		 >512
512
512		 >512
>512
>512		 >512
64(>8)S
256(>2)S
TET 0
MIC/2
MIC/5		 64
32(2)S
32(2)S 		256
128(2)S
128(2)S 		8
2(4)S
2(4)S 		128
64(2)S
64(2)S 		512
256(2)S
256(2)S 		8
2(4)S
4(2)S 		8
2(4)S
4(2)S 		16
4(4)S
16(1)I 		32
8(4)S
8(4)S 		8
4(2)S
8(1)I
CLX 0
MIC/2
MIC/5		 32
16(2)S
32(1)I 		>512
>512
>512		 >512
512
512		 >512
>512
>512		 >512
>512
>512		 128
32(4)S
128(1)I 		>512
>512
>512		 >512
>512
>512		 >512
>512
>512		 >512
128(>4)S
>512
KAN 0
MIC/2
MIC/5		 ≤4
≤4
≤4		 512
32(16)S
256(2)S 		16
16(1)I
16(1)I 		≤4
≤4
≤4		 ≤4
≤4
≤4		 >512
512
>512		 32
4(8)S
16(2)S 		512
256(2)S
512(1)I 		32
≤4(>8)S
32(1) S 		128
16(8)S
64(2)S
ERY 0
MIC/2
MIC/5		 64
16(4)S
64(1)I 		512
32(16)S
512(1)I 		16
16(1)I
16(1)I 		256
16(16)S
32(8)S 		64
16(4)S
16(4)S 		8
4(2)S
8(1)I 		64
64(1)I
64(1)I 		128
16(8)S
32(4)S 		128
128(1)I
128(1)I 		256
32(8)S
256(1)I
NOR 0
MIC/2
MIC/5		 32
8(4)S
16(2)S 		512
128(4)S
256(2)S 		128
64(2)S
128(1)I 		16
4(4)S
8(2)S 		16
8(2)S
8(2)S 		32
8(4)S
32(1)I 		128
32(4)S
128(1)I 		64
8(8)S
16(4)S 		64
32(2)S
32(2)S 		256
256(1)I
256(1)I
FEP 0
MIC/2
MIC/5		 512
512(1)I
512(1)I 		>512
512 (>1)
512(>1)		 >512
>512
>512		 >512
256(>2)S
256(>2)S 		>512
>512
>512		 >512
>512
>512		 >512
>512
>512		 512
256(2)S
512(1)S 		512
512(1)I
512(1)I 		>512
512(>1)
512(>1)
Open in a new tab

(): fold increase in MIC values of the antibiotics after association with plants extract; S: synergy; I: indifference; AMP: ampicillin; FEP: cefepime; CHL: chloramphenicol; KAN: kanamycin; NOR: norfloxacin; STR: streptomycin; TET: tetracycline; CIP: ciprofloxacin; CLX: cloxacillin; ERY: erythromycin.

4. Discussion

4.1. Antibacterial Activities and Chemicals Compositions of the Tested Extracts

The phytochemical studies revealed the presence of at least two classes of secondary metabolites in each of the plant extracts. Several alkaloids, flavonoids, phenols, saponins, anthocyanins, anthraquinones, sterols, tannins, and triterpenes have been found active on pathogenic microorganisms [44, 45]. Some of these compounds were found to be present in the plant species under this study, and they could contribute to the observed antimicrobial activities of some plant extracts. The results of the phytochemical test on G. kola are in accordance with those obtained by Onayade et al., [46, 47]. Many compounds have been isolated from G. kola, such as kolaflavone and 2-hydroxybiflavone [48–50] but their antimicrobials activities have not been evaluated. However, Adegboye et al. [51] reported the activity of G. kola on some streptomycin-sensitive Gram-positive bacteria strain. The present study therefore provides additional information on the antibacterial potential of this plant on MDR bacteria.

The previous phytochemical analyses on hexane extract from the seeds of G. lucida revealed several types of compounds [8, 23]. These include terpenoids, anthocyanins, flavonoids, and saponins derivatives. This report therefore agrees well with the phytochemical data being reported herein.

The results of the phytochemical analysis of the extract of fruits of P. nitida are similar to those obtained by Kouitcheu [52]. Several alkaloids previously isolated from this plant include akuammicine, akuammine, akuammidine, picraphylline, picraline, and pseudoakuammigine [32, 53]. Their antibacterial activities have not yet been demonstrated but many alkaloids are known to be active on Gram-negative bacteria [33]. Differences were noted in the chemical composition of the seeds and fruits of P. nitida, evidently explaining the differences in the antibacterial activity of the two parts of this plant. In fact, the presence of tannins in the fruits may contributes to its better activity compared to the seeds as they were reported to inactivate the microbial adhesins, enzymes, transports proteins and cellular envelop [54].

Extracts from C. papaya, C. medica, B. coriacea, A. cepa, and C. acuminata showed weak activities against a limited number of strains. Nonetheless, the extracts from B. coriacea were rather reported to have good antibacterial activities. Their weak activities as observed in the present paper could therefore be due to the multidrug resistance of the studied bacteria.

4.2. Effects of the Association of Some Plants Extracts with Antibiotics

Three of the most active plants extracts (G. kola, G. lucida, and P. nitida) were associated with antibiotics with the aim to evaluate the possible synergistic effects of their associations. A preliminary study using P. aeruginosa PA124, one of the ten MDR bacteria used in this paper, was carried out with ten antibiotics (CLX, AMP, ERY, KAN, CHL, TET, FEP, STR, CIP, and NOR) to select the appropriate sub-inhibitory concentrations of the extract to be used. The results (see Supplemental Material S1) allowed the selection of G. kola, G. lucida and their MIC/2 and MIC/5 as the sub-inhibitory concentrations. No antagonistic effect (FIC ≥ 4) was observed between extracts and antibiotics meanwhile indifference was observed in the case of CLX, FEP, AMP, which are β-lactams acting on the synthesis of the bacteria cell wall [55] (Tables 5 and 6, Supplemental Material S2). Many studies demonstrated that efflux is the mechanism of resistance of bacteria for almost all antibiotic classes [56]. It is well demonstrated that the efflux pumps reduce the intracellular concentration of antibiotics and consequently their activities [57]. The MDR bacteria strains used in this paper are known for their ability to overexpress active efflux [58]. At MIC/2, synergistic effects were noted with the association of NOR, CHL, TET (on 100% the studied bacteria), ERY (on 80%), CIP (on 70%), and P. nitida extract meanwhile G. kola extract also increased the activity of NOR, TET (on 100%), ERY, and CIP (on 70%). Plant can be considered as an efflux pumps inhibitor if a synergistic effect with antibiotics is induced on more than 70% bacteria expressing active efflux pumps [6]. Therefore, the extracts from P. nitida and G. kola probably contain compounds that can acts as EPI. The results of the present paper corroborate with those of Iwu et al. [7] reporting the existence of synergy effects between G. kola extract and gatifloxacin (G. kola/gatifloxacin in the proportions of 9/1, 8/2, 7/3, and 6/4) against Bacillus subtilis and the proportions of G. kola/gatifloxacin (at 9/1, 2/8, and 1/9) against Staphylococcus aureus.

The overall results of the present work provide baseline information for the possible use of the studied plants and mostly G. Lucida, G. Kola, and P. Nitida extracts in the treatment of bacterial infections involving MDR phenotypes. In addition, the extracts of these plants could be used in association with common antibiotics to combat multidrug resistant pathogens.

Acknowledgments

The authors are thankful to the Cameroon National Herbarium (Yaounde) and University of Dschang Herbarium for plants identification.

References

  • 1.Koyama J. Anti-infective quinone derivatives of recent patents. Recent Patents on Anti-infective Drug Discovery. 2006;1(1):113–125. doi: 10.2174/157489106775244073. [DOI] [PubMed] [Google Scholar]
  • 2.Lomovskaya O, Watkins W. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. Journal of Molecular Microbiology and Biotechnology. 2001;3(2):225–236. [PubMed] [Google Scholar]
  • 3.Harborne JB. Phytochemical Methods. New York, NY, USA: Chapman and Hall; 1973. [Google Scholar]
  • 4.Mativandlela SPN, Lall N, Meyer JJM. Antibacterial, antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root extracts. South African Journal of Botany. 2006;72(2):232–237. [Google Scholar]
  • 5.Kuete V, Ngameni B, Simo CCF, et al. Antimicrobial activity of the crude extracts and compounds from Ficus chlamydocarpa and Ficus cordata (Moraceae) Journal of Ethnopharmacology. 2008;120(1):17–24. doi: 10.1016/j.jep.2008.07.026. [DOI] [PubMed] [Google Scholar]
  • 6.Athamna A, Athamna M, Nura A, et al. Is in vitro antibiotic combination more effective than single-drug therapy against anthrax? Antimicrobial Agents and Chemotherapy. 2005;49(4):1323–1325. doi: 10.1128/AAC.49.4.1323-1325.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Iwu MW, Duncan AR, Okunji CO. News antimicrobials of plant origin. In: Janick J, editor. Perspectives on New Crops and New Uses. Alexandria, Va, USA: ASHS Press; 1999. pp. 457–462. [Google Scholar]
  • 8.Guedje NM, Fankap R. Utilisations traditionnelles de Garcinia lucida et Garcinia kola (Clusiaceae) au Cameroun, Phytogeography for the Understanding of African Plant Systematics and Biodiversity, Systematics and Geography of Plants. National Botanic Garden of Belgium. 2001;71(2):747–758. [Google Scholar]
  • 9.Abdou IA, Abou-Zeid AA, El-Sherbeeny MR, Abou-El-Gheat ZH. Antimicrobial activities of Allium sativum, Allium cepa, Raphanus sativus, Capsicum frutescens, Eruca sativa, Allium kurrat on bacteria. Plant Foods for Human Nutrition, Chemistry and Material Science. 2010;22:29–35. [Google Scholar]
  • 10.Quisumbing E. Medicinal Plants of the Philippines. Manila, Philippines: Katha; 1978. [Google Scholar]
  • 11.Lohiya NK, Pathak N, Mishra PK, Manivannan B. Contraceptive evaluation and toxicological study of aqueous extract of the seeds of Carica papaya in male rabbits. Journal of Ethnopharmacology. 2000;70(1):17–27. doi: 10.1016/s0378-8741(99)00139-7. [DOI] [PubMed] [Google Scholar]
  • 12.Osato JA, Librado A, Gemma MR, et al. Antimicrobial and Antioxidant Activities of Unripe Papaya. Gifu, Japan: Sun-O International; 1993. [DOI] [PubMed] [Google Scholar]
  • 13.Mbota TI, Duru CM, Onwumelu HA. Antibacterial activity of crude seed extracts of Buchholzia coriaceae on some pathogenic bacteria. Journal of Developmental Biology and Tissue Engineering. 2009;1(1):001–005. [Google Scholar]
  • 14.Ajaiyeoba EO, Onocha PA, Nwozo SO, Sama W. Antimicrobial and cytotoxicity evaluation of Buchholzia coriacea stem bark. Fitoterapia. 2003;74(7-8):706–709. doi: 10.1016/s0367-326x(03)00142-4. [DOI] [PubMed] [Google Scholar]
  • 15. http://en.wikipedia.org/wiki/Citrus_medica. citron, 2010.
  • 16.Kuete V, Penlap V, Etoa FX, et al. Activités antimicrobienne de l'extrait total et des fractions de jus de fruit de Citrus medica Linn. (Rutaceae) Pharmacopee et Medecine Traditionelle Africaine. 2004;13:91–101. [Google Scholar]
  • 17.Cola acuminata. http://en.wikipedia.org/wiki/Cola_acuminata, 2010.
  • 18.Uko OJ, Usman A, Ataja AM. Some biological activities of Garcinia kola in growing rats. Veterinarski Arhiv. 2001;71(5):287–297. [Google Scholar]
  • 19.Kuete V, Krusche B, Youns M, et al. Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. Journal of Ethnopharmacology. 2011;134(3):803–812. doi: 10.1016/j.jep.2011.01.035. [DOI] [PubMed] [Google Scholar]
  • 20.Iwu MM. Handbook of African Medicinal Plants. London, UK: CRC Press; 1993. [Google Scholar]
  • 21.Hussain RA, Owegby AG, Waterman PG. Kolanone, a novel polyisoprenylated benzophenone with antimicrobial properties from the fruit of Garcinia kola . Planta Medica. 1982;44(2):78–81. doi: 10.1055/s-2007-971406. [DOI] [PubMed] [Google Scholar]
  • 22.Akoachere JF, Ndip RN, Chenwi RB, Ndip LM, Njock TE, Anong DE. Antibactirial effect of Zingiber officinale and Garcinia kola on respiratory track pathogens. East African Medicinal Journal. 2002;79(11):588–592. doi: 10.4314/eamj.v79i11.8804. [DOI] [PubMed] [Google Scholar]
  • 23.Nyemba AM, Mpondo TN, Connolly JD, Rycroft DS. Cycloartane derivatives from Garcinia lucida . Phytochemistry. 1990;29(3):994–997. [Google Scholar]
  • 24.Fotie J, Bohle DS, Olivier M, Gomez MA, Nzimiro S. Trypanocidal and antileishmanial dihydrochelerythrine derivatives from Garcinia lucida . Journal of Natural Products. 2007;70(10):1650–1653. doi: 10.1021/np0702281. [DOI] [PubMed] [Google Scholar]
  • 25.Gangoué-Piéboji J. Caractérisation des β-Lactamases et leur inhibition par les extraits de plantes médicinales. Université de Liège, Centre d’Ingénierie des Protéines; 2007. Thèse présenté en vue d’obtention du diplôme de Doctorat ès Sciences en Biochimie. [Google Scholar]
  • 26.Kirby GC, Khumalo-Ngwenya NB, Grawehr BA, Fison TW, Warhurst DC, Phillipson JD. Antimalarial activity from ’Mhekara’ (Uapaca nitida Mull-Arg.), a Tanzanian tree. Journal of Ethnopharmacology. 1993;40(1):47–51. doi: 10.1016/0378-8741(93)90088-m. [DOI] [PubMed] [Google Scholar]
  • 27.Likhitwitayawuid K, Angerhofer CK, Cordell GA, Pezzuto JM, Ruangrungsri N. Traditional medicinal plants of Thailand. 20. Cytotoxic and antimalarial bisbenzylisoquinoline alkaloids from Stephania erecta . Journal of Natural Products. 1993;56:38 pages. doi: 10.1021/np50091a005. [DOI] [PubMed] [Google Scholar]
  • 28.Xu ME, Xiao SZ, Sun YH, Ou Y, Guan C, Zheng XX. A preadipocyte differentiation assay as a method for screening potential anti-type II diabetes drugs from herbal extracts. Planta Medica. 2006;72(1):14–19. doi: 10.1055/s-2005-916215. [DOI] [PubMed] [Google Scholar]
  • 29.Shittu H, Gray A, Furman B, Young L. Glucose uptake stimulatory effect of akuammicine from Picralima nitida (Apocynaceae) Phytochemistry Letters. 2010;3(1):53–55. [Google Scholar]
  • 30.François G, Aké Assi L, Holenz J, Bringmann G. Constituents of Picralima nitida display pronounced inhibitory activities against asexual erythrocytic forms of Plasmodium falciparum in vitro. Journal of Ethnopharmacology. 1996;54(2-3):113–117. doi: 10.1016/s0378-8741(96)01456-0. [DOI] [PubMed] [Google Scholar]
  • 31.Viveiros M, Jesus A, Brito M, et al. Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes. Antimicrobial Agents and Chemotherapy. 2005;49(8):3578–3582. doi: 10.1128/AAC.49.8.3578-3582.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Nkere CK, Iroegbu CU. Antibacterial screening of the root, seed and stembark extracts of Picralima nitida . African Journal of Biotechnology. 2005;4(6):522–526. [Google Scholar]
  • 33.Kuete V. Potential of Cameroonian plants and derived products against microbial infections: a review. Planta Medica. 2010;76(14):1479–1491. doi: 10.1055/s-0030-1250027. [DOI] [PubMed] [Google Scholar]
  • 34.Okusu H, Ma D, Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. Journal of Bacteriology. 1996;178(1):306–308. doi: 10.1128/jb.178.1.306-308.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Elkins CA, Mullis LB. Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli . Antimicrobial Agents and Chemotherapy. 2007;51(3):923–929. doi: 10.1128/AAC.01048-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Baglioni P, Bini L, Liberatori S, Pallini V, Marri L. Proteome analysis of Escherichia coli W3110 expressing an heterologous sigma factor. Proteomics. 2003;3(6):1060–1065. doi: 10.1002/pmic.200300403. [DOI] [PubMed] [Google Scholar]
  • 37.Ghisalberti D, Masi M, Pagès JM, Chevalier J. Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes . Biochemical and Biophysical Research Communications. 2005;328(4):1113–1118. doi: 10.1016/j.bbrc.2005.01.069. [DOI] [PubMed] [Google Scholar]
  • 38.Malléa M, Mahamoud A, Chevalier J, et al. Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochemical Journal. 2003;376(3):801–805. doi: 10.1042/BJ20030963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mallea M, Chevalier J, Bornet C, et al. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes . Microbiology. 1998;144(11):3003–3009. doi: 10.1099/00221287-144-11-3003. [DOI] [PubMed] [Google Scholar]
  • 40.Pradel E, Pagès JM. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes . Antimicrobial Agents and Chemotherapy. 2002;46(8):2640–2643. doi: 10.1128/AAC.46.8.2640-2643.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Chevalier J, Pagès JM, Eyraud A, Malléa M. Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae . Biochemical and Biophysical Research Communications. 2000;274(2):496–499. doi: 10.1006/bbrc.2000.3159. [DOI] [PubMed] [Google Scholar]
  • 42.Tran QT, Mahendran KR, Hajjar E, et al. Implication of porins in β-lactam resistance of Providencia stuartii . Journal of Biological Chemistry. 2010;285(42):32273–32281. doi: 10.1074/jbc.M110.143305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lorenzi V, Muselli A, Bernardini AF, et al. Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species. Antimicrobial Agents and Chemotherapy. 2009;53(5):2209–2211. doi: 10.1128/AAC.00919-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Otshudi AL, Vercruysse A, Foriers A. Contribution to the ethnobotanical, phytochemical and pharmacological studies of traditionally used medicinal plants in the treatment of dysentery and diarrhoea in Lomela area, Democratic Republic of Congo (DRC) Journal of Ethnopharmacology. 2000;71(3):411–423. doi: 10.1016/s0378-8741(00)00167-7. [DOI] [PubMed] [Google Scholar]
  • 45.Havagiray R, Ramesh C, Sadhna K. Study of antidiarrhoeal activity of Calotropis gigantean in experimental animals. Journal of Pharmacology and Pharmaceutical Science. 2004;7(1):70–75. [Google Scholar]
  • 46.Onayade OA, Looman AMG, Scheffer JJC, Gbile ZO. lactone and other volatile constituents of the oleoresin from seeds of Garcinia kola hechel. Flavour Frangrance Journal. 1998;13(6):409–412. [Google Scholar]
  • 47.Ebana RUB, Madunagu BE, Ekpe ED, Otung IN. Microbiological exploitation of cardiac glycosides and alkaloids from Garcinia kola, Borreria ocymoides, Kola nitida and Citrus aurantifolia . Journal of Applied Bacteriology. 1994;71(5):398–401. doi: 10.1111/j.1365-2672.1991.tb03807.x. [DOI] [PubMed] [Google Scholar]
  • 48.Okunji CO, Iwu MM. Molluscicidal activity of Garcinia kola biflavanones. Fitoterapia. 1991;62(1):74–76. [Google Scholar]
  • 49.Terashima K, Kondo Y, Aqil M, Waziri M, Niwa M. A study of biflavanones from the stems of Garcinia kola (Guttiferae) Heterocycles. 1999;50(1):283–290. [Google Scholar]
  • 50.Okunji CO, Tantalia AW, Hicks RP, Iwu MM, Skanchy DJ. Capilary determination of biflavonones from Garcinia kola in three traditional African medical formulations. Planta Medica. 2002;68:440–444. doi: 10.1055/s-2002-32091. [DOI] [PubMed] [Google Scholar]
  • 51.Adegboye MF, Akinpelu DA, Okoh AI. The bioactive and phytochemical properties of Garcinia kola (Heckel) seed extract on some pathogens. African Journal of Biotechnology. 2008;7(21):3934–3938. [Google Scholar]
  • 52.Kouitcheu MLB. Evaluation des propriétés anti-diarrhéiques et de la toxicité de Cylecodicus gabunensis (Mimosaceae) et Picralima nitida (Apocynaceae), plantes médicinales utilisées dans le traitement des maladies diarrhéiques. Yaoundé, Cameroun: Université de Yaoundé; 2007. Thèse de Doctorat/PHD en Biochimie. [Google Scholar]
  • 53.François G, Aké Assi L, Holenz J, Bringmann G. Constituents of Picralima nitida display pronounced inhibitory activities against asexual erythrocytic forms of Plasmodium falciparum in vitro. Journal of Ethnopharmacology. 1996;54(2-3):113–117. doi: 10.1016/s0378-8741(96)01456-0. [DOI] [PubMed] [Google Scholar]
  • 54.Cowan MM. Plant products as antimicrobial agents. Clinical Microbiology Reviews. 1999;12(4):564–582. doi: 10.1128/cmr.12.4.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs. 2004;64(2):159–204. doi: 10.2165/00003495-200464020-00004. [DOI] [PubMed] [Google Scholar]
  • 56.Van Bambeke F, Pages J-M, Lee VJ. Inhibitor of bacterial efflux pumps as adjuvants in antibacterial therapy and diagnostic tools for detection of resistance by efflux. Frontier in Anti-Infective Drug Discovery. 2010;1:170–175. doi: 10.2174/157489106777452692. [DOI] [PubMed] [Google Scholar]
  • 57.Kuete V, Ngameni B, Tangmouo JG, et al. Efflux pumps are involved in the defense of gram-negative bacteria against the natural products isobavachalcone and diospyrone . Antimicrobial Agents and Chemotherapy. 2010;54(5):1749–1752. doi: 10.1128/AAC.01533-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Ofokansi KC, Mbanefo AN, Ofokansi MN, Esimone CO. Antibacterial interaction of crude methanol extract of Garcinia kola seed with gatifloxacin. Tropical Journal of Pharmacological Research. 2008;7(4):1159–1165. [Google Scholar]

Articles from Evidence-based Complementary and Alternative Medicine : eCAM are provided here courtesy of Wiley

RESOURCES